Clinical Genomics & Molecular Diagnostics
10:00 – 17:00
|Dr Anna Schuh
Director of Molecular Diagnostics,
Honorary Consultant Haematologist,
University of Oxford, UK
The full programme can be viewed HERE
Who should attend?
This meeting is ideal for:
- Researchers and
and any healthcare professionals who have an interest in the future shape and direction of FL & CLL research and treatment.
Continuing Professional Development (CPD) accreditation for this meeting has been applied to the Royal College of Physicians and more information will be available shortly.
When & Where
Monday 19th November 2018, 09:30 – 17:00
Oxford Spires Hotel,
Oxford. OX1 4PS.
The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.
Date of preparation: August 2018
This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.